Digital Strategies To Power Next-Generation BioPharma

The current state of biopharma drug development is a barrier to timely and cost-effective treatment of disease. Legacy software systems are helping to eliminate paper records, but haven’t solved the fundamental challenge of bridging data silos.

IDBS research indicates that these inefficiencies are adding up to three years to the development process. Learn about a system for efficiently navigating processes, managing data, and gaining knowledge throughout development to tackle challenges in scale-up and tech transfers.